Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
leuprolide acetate + bicalutamide
- Development stage
- Phase 3
- Lead developer
- Takeda
- Modality
- Small Molecules, Peptides
- Administration
- Intramuscular, Subcutaneous, Oral
01
Overview
Leuprolide acetate + bicalutamide is a combination therapy used primarily for the treatment of metastatic prostate cancer. Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist that suppresses the production of testosterone by downregulating pituitary secretion of luteinizing hormone, leading to medical castration. Bicalutamide is a nonsteroidal antiandrogen that blocks androgen receptors, preventing testosterone from stimulating prostate cancer cell growth. This combination is commonly used to achieve maximal androgen blockade and reduce tumor flare associated with initial GnRH agonist therapy[1][2][3][4][5][8].
- Brand names
- Bi ELIGARD cp
- Other names
- leuprorelin acetatebicalutamide
02
Targets
AR (Adrenergic receptors)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on leuprolide acetate + bicalutamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on leuprolide acetate + bicalutamide.